Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Biology and treatment of myeloma.

Brioli A, Melchor L, Walker BA, Davies FE, Morgan GJ.

Clin Lymphoma Myeloma Leuk. 2014 Sep;14 Suppl:S65-70. doi: 10.1016/j.clml.2014.06.011. Review.

PMID:
25486959
2.

Multiple myeloma: new aspects of biology and treatment.

Ozaki S, Kosaka M.

J Med Invest. 1998 Feb;44(3-4):127-36. Review.

PMID:
9597800
3.

Precision Medicine in Myeloma: Challenges in Defining an Actionable Approach.

González-Calle V, Keane N, Braggio E, Fonseca R.

Clin Lymphoma Myeloma Leuk. 2017 Oct;17(10):621-630. doi: 10.1016/j.clml.2017.06.021. Epub 2017 Jun 23. Review.

PMID:
28743429
4.

Myeloma Is Not a Single Disease.

Lonial S, Nooka AK.

J Oncol Pract. 2016 Apr;12(4):287-92. doi: 10.1200/JOP.2016.010926. Review.

PMID:
27072380
5.

Genomics in multiple myeloma: biology and clinical implications.

Chng WJ, Fonseca R.

Pharmacogenomics. 2005 Sep;6(6):563-73.

PMID:
16142997
6.

Advances in understanding prognosis in myeloma.

Smith D, Yong K.

Br J Haematol. 2016 Nov;175(3):367-380. doi: 10.1111/bjh.14304. Epub 2016 Sep 8. Review.

PMID:
27604166
7.

[Monoclonal gammopathies--from MGUS to myeloma].

Hess U, Heijnen IA.

Ther Umsch. 2004 Feb;61(2):161-7. German.

PMID:
15018400
8.

How to use new biology to guide therapy in multiple myeloma.

Morgan GJ, Kaiser MF.

Hematology Am Soc Hematol Educ Program. 2012;2012:342-9. doi: 10.1182/asheducation-2012.1.342. Review.

PMID:
23233602
9.

Multiple myeloma: an old disease with new hope for the future.

Zaidi AA, Vesole DH.

CA Cancer J Clin. 2001 Sep-Oct;51(5):273-85; quiz 286-9. Review. Erratum in: CA Cancer J Clin 2002 Jan-Feb;52(1):60.

10.

Current Review on High-Risk Multiple Myeloma.

Chan HSH, Chen CI, Reece DE.

Curr Hematol Malig Rep. 2017 Apr;12(2):96-108. doi: 10.1007/s11899-017-0368-z. Review.

PMID:
28317082
11.
12.

Myeloma bone disease: recent advances in biology, diagnosis, and treatment.

Sezer O.

Oncologist. 2009 Mar;14(3):276-83. doi: 10.1634/theoncologist.2009-0003. Epub 2009 Mar 13. Review.

13.

[Classification and genetic abnormalities of multiple myeloma].

Hanamura I, Iida S.

Nihon Rinsho. 2015 Jan;73(1):17-27. Review. Japanese.

PMID:
25626298
14.

Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.

Bianchi G, Anderson KC.

CA Cancer J Clin. 2014 Nov-Dec;64(6):422-44. doi: 10.3322/caac.21252. Epub 2014 Sep 29. Review.

15.

Addiction to c-MYC in multiple myeloma.

Holien T, Våtsveen TK, Hella H, Waage A, Sundan A.

Blood. 2012 Sep 20;120(12):2450-3. Epub 2012 Jul 17.

16.

Multiple myeloma: recognition and management.

George ED, Sadovsky R.

Am Fam Physician. 1999 Apr 1;59(7):1885-94. Review.

17.

[Advances Research on C-MYC Proto-oncogene in Multiple Myeloma -Review].

Huang H, Guo WJ, Yao RX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1248-51. doi: 10.7534/j.issn.1009-2137.2016.04.053. Review. Chinese.

PMID:
27531809
18.

Multiple myeloma: an overview of diagnosis and management.

Hussein M.

Cleve Clin J Med. 1994 Jul-Aug;61(4):285-98. Review.

PMID:
7923747
19.

Clinical roundtable monograph. Emerging treatment options for relapsed and refractory multiple myeloma.

Siegel DS, Vij R, Jakubowiak AJ.

Clin Adv Hematol Oncol. 2011 Apr;9(4):1-15.

PMID:
21928467
20.

Multiple myeloma, a model for fundamental and clinical research.

Vande Broek I, Asosingh K, Vanderkerken K, Van Riet I, Van Camp B.

Verh K Acad Geneeskd Belg. 2002;64(4):261-84; discussion 284-6. Review.

PMID:
12416235

Supplemental Content

Support Center